Medlab

What Medlab does

Medlab, Inc. is a privately held, CLIA-certified high-complexity clinical laboratory founded in 1994 and headquartered in Cheektowaga (Buffalo), New York. The company operates a single regional laboratory serving the Western New York area with a 30+ year track record, employing between 11 and 50 staff and maintaining tenured personnel averaging 10+ years of tenure. Medlab generates revenue by performing clinical laboratory testing services billed to insurance carriers and patients, anchored in presumptive toxicology screening and LC-MS/GC-MS definitive confirmatory testing across 70+ analytes, alongside molecular RT-PCR diagnostics including a combined COVID-19/Flu A&B/RSV single-swab panel and Streptococcus A detection.

The laboratory's underlying technology stack is built on LC-MS and GC-MS mass spectrometry for toxicology and RT-PCR (with FDA Emergency Use Authorization for COVID-19) for infectious disease testing, supported by layered regulatory credentials: CLIA high-complexity certification, College of American Pathologists accreditation, New York State Department of Health CLEP licensure, and Medicare provider certification. Medlab differentiates through an in-house, non-outsourced testing model (no samples sent out of state), daily local driver specimen pickup enabling same-day results for Western NY providers, EMR integration with major electronic medical record systems, an online ordering and results portal, and a proprietary onsite kiosk system that embeds ordering and specimen placement into provider facilities.

Medlab's go-to-market is regional and direct: institutional sales to healthcare providers (physicians, treatment agencies, courts, hospitals, schools, long-term care facilities) via phone, online portal, and EMR, paired with direct-to-consumer walk-in and drive-up respiratory testing at the Cheektowaga location, online appointment scheduling, and a self-serve patient results portal. Pricing is transaction-based at approximately $200 per COVID PCR test with insurance billing across most major carriers, and customer segments span substance abuse and mental health treatment, pain management, criminal justice (probation, drug courts, NYS parole, DSS), and community respiratory illness testing. The company is independently operated with no disclosed parent, private equity, or venture capital backing.

Name

Medlab

Legal name

Medlab, Inc.

Website

https://medlabinc.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

Medlab, Inc. is a privately held, CLIA-certified high-complexity clinical laboratory in Cheektowaga, New York, providing toxicology screening and LC-MS/GC-MS confirmatory testing alongside molecular RT-PCR diagnostics (COVID-19, Flu, RSV, Strep A) to healthcare providers, criminal justice agencies, and individual patients in Western New York.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Clinical laboratory testing
• Toxicology screening services
• Molecular diagnostic testing
• Respiratory pathogen PCR
• Pain management testing

Headquarters

HQ city

Buffalo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Clinical Laboratory Testing Services: Medlab generates revenue primarily through laboratory testing services billed directly to insurance carriers or paid by patients. They perform presumptive screening, definitive confirmatory testing, and molecular diagnostics. Insurance coverage varies by plan; some Blue Cross plans pay policyholders directly who then reimburse Medlab.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Medlab is a CLIA-certified, high-complexity clinical laboratory that performs presumptive and definitive toxicology testing and molecular diagnostic (RT-PCR) testing for healthcare providers, criminal justice agencies, treatment centers, and individual patients. The laboratory uses LC-MS, GC-MS, and RT-PCR instrumentation to deliver 70+ analyte toxicology panels and combined respiratory pathogen panels, with results typically returned within 24 hours. Services are supported by an online ordering/results portal, EMR integration, daily local driver pickup, and a proprietary onsite kiosk system for specimen management.

Product overview

Medlab is a CLIA-certified clinical laboratory offering a unified portfolio of toxicology and molecular diagnostic testing services. The core offering includes presumptive screening and definitive LC-MS/GC-MS confirmatory testing covering 70+ analytes, combined with molecular RT-PCR panels for respiratory and infectious disease detection including COVID-19, Flu, and RSV. The company provides an integrated online portal for ordering, results delivery, and patient management, complemented by an optional proprietary kiosk system for onsite specimen management. Testing services span substance abuse and mental health, pain management, criminal justice, and community health applications.

Differentiator

Problem solved

Functional benefit

Products and services

• COVID-19, Flu, and RSV PCR Testing Single RT-PCR molecular test that detects COVID-19, Influenza A & B, and Respiratory Syncytial Virus (RSV) from a single swab specimen, with same or next day results; offered to individual patients via walk-in and drive-up testing and to providers via the ordering portal.
• Presumptive Toxicology Screening Fast, cost-effective presumptive screening performed by professional toxicologists covering a wide range of substances including medications, alcohol, amphetamines, illicit compounds, and opioids; results delivered next-day via the online portal for healthcare providers, treatment agencies, and criminal justice entities.
• Definitive Toxicology Confirmatory Testing LC-MS and GC-MS technology-based definitive confirmation testing that rules out false positives and identifies substances or metabolites not detected by presumptive methods; covers 70+ unique analytes including opioids, benzodiazepines, fentanyl analogs, stimulants, and emerging substances.
• Molecular Diagnostic RT-PCR Testing Advanced molecular diagnostic test panels using RT-PCR DNA analysis for rapid identification of multiple pathogens simultaneously, including COVID-19, RSV, Influenza A & B, and Streptococcus A, enabling clinicians to make decisions based on highly accurate pathogen identification.
• Online Patient Results Portal Web-based portal that allows patients and providers to securely view test results online after verifying patient ID and date of visit; includes patient test history to support medical necessity and prevent excess testing.

Quantifiable outcome

• 24-hour typical turnaround time from sample receipt
• +5 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• LabCorp (Laboratory Corporation of America): LabCorp is one of the largest clinical laboratory networks in the world, offering toxicology, molecular diagnostics, and routine testing with national logistics. Competes with Medlab broadly across all test categories but at vastly greater scale and breadth.
• Sonic Healthcare USA: Sonic Healthcare USA is a network of regional clinical laboratories offering toxicology, anatomic pathology, and molecular diagnostics across multiple U.S. regions. Competes broadly with Medlab in toxicology and is a potential strategic acquirer given its roll-up history.
• Quest Diagnostics: Quest Diagnostics is the largest U.S. clinical laboratory, offering toxicology, infectious disease PCR, and routine diagnostics with national courier logistics and EMR integrations. Overlaps with Medlab on toxicology and respiratory PCR, but with national scale and substantially broader test menus.

Direct peers

• USDTL (United States Drug Testing Laboratories): USDTL is a specialty laboratory specializing in drug and alcohol toxicology testing, including LC-MS/MS confirmation, hair, urine, and oral fluid testing for courts, treatment programs, and physicians. Closely aligned with Medlab's toxicology and criminal-justice offerings.
• Aegis Sciences Corporation: Aegis is a specialty clinical laboratory focused on toxicology, pain management, and drug testing using LC-MS/MS technology, serving healthcare providers and criminal justice customers nationwide. Directly comparable to Medlab's toxicology business in panel depth, methodology, customer segments, and reimbursement model.
• Precision Diagnostics: Precision Diagnostics is a clinical laboratory providing comprehensive toxicology, pain management, and pharmacogenomics testing using LC-MS/MS to physicians and treatment centers. Direct competitor in pain management and substance abuse toxicology segments.
• Dominion Diagnostics: Dominion is a specialty toxicology laboratory offering LC-MS/MS-based drug monitoring and medication adherence testing for substance abuse treatment, pain management, and behavioral health. Overlaps with Medlab on customer base, methodology, and use cases.

Regional players

• ACM Medical Laboratory: ACM Medical Laboratory is a CLIA-certified, CAP-accredited regional clinical laboratory based in Rochester, NY, serving Western and Central New York with toxicology, molecular, and routine testing. Comparable regional footprint and service mix to Medlab in the same New York State geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/medlabcares
• LinkedInlinkedin.com/company/medlab-inc

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medlab